IKKα signalling at the crossroads of development, disease and drug discovery
Cellular Signalling · 2026-09 · 145 · 112585
DOI: 10.1016/j.cellsig.2026.112585 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cellular Signalling, 2026-09. Verfasst von Kirsty Tinto und 2 weiteren Autor:innen. Beteiligte Einrichtung: Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, G4 0RE, United Kingdom. Electronic address: kirsty.tinto@strath…. Hauptthemen laut MEDLINE: I-kappa B Kinase, Signal Transduction, Drug Discovery, Neoplasms. Die Arbeit nennt 168 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: British Pharmacological Society, University of Strathclyde, Children's Cancer and Leukaemia Group.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, G4 0RE, United Kingdom. Electronic address: kirsty.tinto@strath.ac.uk.
- Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, G4 0RE, United Kingdom.
Förderung
- British Pharmacological Society
- University of Strathclyde
- Children's Cancer and Leukaemia Group
- Bone Cancer Research Trust
Zitieren
APA
Tinto, K., Cunningham, M., & Plevin, R. (2026). IKKα signalling at the crossroads of development, disease and drug discovery. Cellular Signalling, 145, 112585. https://doi.org/10.1016/j.cellsig.2026.112585
Vancouver
Tinto K, Cunningham M, Plevin R. IKKα signalling at the crossroads of development, disease and drug discovery. Cellular Signalling. 2026;145:112585. doi:10.1016/j.cellsig.2026.112585
BibTeX
@article{Tinto2026,
author = {Tinto, Kirsty and Cunningham, Margaret and Plevin, Robin},
title = {IKKα signalling at the crossroads of development, disease and drug discovery},
journal = {Cellular Signalling},
year = {2026},
volume = {145},
pages = {112585},
doi = {10.1016/j.cellsig.2026.112585}
}
EUVIMED